|
INVA | Innoviva, Inc. |
|
|
INVA | Innoviva, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.76 |
| Leverage | 29.33% |
| Market Cap | $ 1.3B |
| PE | 10.50 |
| Dividend Yield | 0.00% |
| Profit | $ 126.2m |
| Margin | 32.33% |
Innoviva, Inc. is dedicated to the development and commercialization of pharmaceutical products. The company is headquartered in Burlingame, California.